FDA advisers panel recommend COVID Booster doses for 65 and older


Food and Drug Administration advisory committee (US FDA) unanimously recommend the third shots to people age 65 and older and those at a high risk of suffering from severe illness if they get the coronavirus.

Rejected a proposal to distribute booster/third shots of Pfizer and BioNTech’s Covid-19 vaccine to the General Public.


Doctors Liked to Read More

In the UK, the government has announced that it will offer boosters to everyone over 50 and to other vulnerable people as it heads towards the winter months.

Germany, France and the Czech Republic have announced similar plans for older or vulnerable people.

In Israel, boosters are already being offered to people as young as 12.


The World Health Organization has called on wealthier nations to hold off on providing booster shots until vaccination rates go up in lesser developed countries.

That’s included people with diabetes, heart disease, obesity and other so-called comorbidities.

The panel also recommended that the FDA include healthcare workers and others at high risk of occupational exposure to the virus that causes COVID-19, such as teachers.

Currently, CDC is recommending that moderately to severely immunocompromised people receive an additional dose. This includes people who have:

  • Been receiving active cancer treatment for tumors or cancers of the blood
  • Received an organ transplant and are taking medicine to suppress the immune system
  • Received a stem cell transplant within the last 2 years or are taking medicine to suppress the immune system
  • Moderate or severe primary immunodeficiency (such as DiGeorge syndrome, Wiskott-Aldrich syndrome)
  • Advanced or untreated HIV infection
  • Active treatment with high-dose corticosteroids or other drugs that may suppress your immune response

https://www.reuters.com/world/us/us-covid-19-booster-debate-moves-fda-vaccine-advisory-committee-2021-09-17/

https://www.cnbc.com/2021/09/17/fda-panel-begins-voting-on-pfizers-covid-booster-doses-rejecting-shots-for-general-public.html

https://www.washingtonpost.com/health/2021/09/17/covid-booster-shots-fda-recommendation/

This is for informational purposes only. You should consult your clinical textbook for advising your patients.